Long-term Response Rates in Chronic and Episodic Migraine Patients with Concomitant Preventive Medication Use: Results from 1-Year Study

被引：0
|
作者：
Goadsby, P. J.
Silberstein, S. D.
Dodick, D. W.
Cohen, J. M.
Yang, R.
Ning, X.
机构：
来源：
HEADACHE | 2019年 / 59卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P110
引用
收藏
页码：97 / 97
页数：1
相关论文
共 50 条
  • [1] Long-term response rates in chronic and episodic migraine patients with concomitant preventive medication use: results of a 1-year study
    Goadsby, Peter J.
    Silberstein, Stephen D.
    Dodick, David W.
    Cohen, Joshua M.
    Yang, Ronghua
    Ning, Xiaoping
    Elms, Shawn
    [J]. CEPHALALGIA, 2019, 39 : 39 - 39
  • [2] Long-term efficacy of fremanezumab in migraine patients with and without concomitant oral preventive medication use: results of a 1-year study
    Goadsby, Peter J.
    Silberstein, Stephen D.
    Dodick, David W.
    Cohen, Joshua M.
    Yang, Ronghua
    Ning, Xiaoping
    Carr, Karen
    [J]. CEPHALALGIA, 2019, 39 : 38 - 38
  • [3] Long-Term Impact of Fremanezumab on Response Rates, Acute Headache Medication Use, and Disability in Patients with Episodic Migraine: Results of a 1-Year Study
    Brandes, J.
    Marmura, M. J.
    Cohen, J. M.
    Gandhi, S. K.
    Yang, R.
    [J]. HEADACHE, 2019, 59 : 122 - 122
  • [4] Long-Term Impact of Fremanezumab on Response Rates, Acute Headache Medication Use, and Disability in Patients with Episodic Migraine: Results of a 1-Year Study
    Brandes, Jan
    Marmura, Michael
    Yeung, Paul
    Cohen, Joshua
    Gandhi, Sanjay
    Yang, Ronghua
    [J]. NEUROLOGY, 2019, 92 (15)
  • [5] Long-term impact of fremanezumab on response rates, acute headache medication use, and disability in patients with episodic migraine: interim results of a 1-year study
    Brandes, Jan L.
    Yeung, Paul P.
    Cohen, Joshua M.
    Gandhi, Sanjay K.
    Fitzgerald, Timothy
    Yang, Ronghua
    Ma, Yuju
    Aycardi, Ernesto
    [J]. JOURNAL OF HEADACHE AND PAIN, 2018, 19
  • [6] Long-Term Efficacy of Fremanezumab in Chronic and Episodic Migraine Patients Who Failed at Least One Prior Migraine Preventive Medication: Results of a 1-Year Study
    Winner, P. K.
    Freeman, M. C.
    Cohen, J. M.
    Yang, R.
    Ning, X.
    [J]. HEADACHE, 2019, 59 : 118 - 119
  • [7] Long-term efficacy of fremanezumab in chronic and episodic migraine patients who failed at least one prior migraine preventive medication: results of a 1-year study
    Winner, Paul K.
    Freeman, Marshall C.
    Cohen, Joshua M.
    Yang, Ronghua
    Ning, Xiaoping
    Blaiss, Cory
    [J]. CEPHALALGIA, 2019, 39 : 36 - 37
  • [8] Long-Term Efficacy of Fremanezumab in Chronic and Episodic Migraine Patients Who Failed at Least One Prior Migraine Preventive Medication: Results of a 1-Year Study
    Winner, Paul K.
    Freeman, Marshall C.
    Cohen, Joshua M.
    Yang, Ronghua
    Ning, Xiaoping
    Ortega, Mario
    [J]. ANNALS OF NEUROLOGY, 2019, 86 : S168 - S169
  • [9] Long-Term Impact of Fremanezumab on Response Rates, Acute Headache Medication Use, and Disability in Patients with Chronic Migraine: Results of a 1-Year Study
    McAllister, P.
    Cohen, J. M.
    Gandhi, S. K.
    Yang, R.
    [J]. HEADACHE, 2019, 59 : 114 - 114
  • [10] Long-Term Impact of Fremanezumab on Response Rates, Acute Headache Medication Use, and Disability in Patients With Chronic Migraine: Results of a 1-Year Study
    McAllister, Peter
    Yeung, Paul P.
    Cohen, Joshua
    Gandhi, Sanjay
    Yang, Ronghua
    [J]. NEUROLOGY, 2019, 92 (15)
12345